Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: Implications for tumorigenesis

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 3054-3058

  Reincke, Martin ^a,c   Mora, Patricia ^a   Beuschlein, Felix ^a   Arlt, Wiebke ^a   Chrousos, George P ^b   Allolio, Bruno ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RECEPTOR; GENE PRODUCT; GUANINE NUCLEOTIDE BINDING PROTEIN; THYROTROPIN;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; CUSHING SYNDROME; DNA POLYMORPHISM; FEMALE; GENE DELETION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; VIRILIZATION;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; CARCINOMA; FEMALE; GENE DELETION; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, CORTICOTROPIN; REFERENCE VALUES; RNA, MESSENGER;

EID: 0030883247     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.9.3054     Document Type: Article

References (26)

1. Ross NS, Aron DC. 1990 Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med. 323:1401-1405.
2. Hough AJ, Hollifield JW, Page DL, et al. 1979 Prognosis factors in adrenocortical tumors. Am J Clin Pathol. 72:390-399.
3. Weiss LM. 1984 Comparative histologic study of 43 metastasing and nonmetastasing adrenocortical tumors. Am J Pathol. 8:163-169.
4. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. 1992 The cloning of a family of genes that encode the melanocortin receptors. Science. 275: 1248-1251.
5. Siegrist W, Eberle AN. 1995 Melanocortins and their implication in melanoma. Trends Endocrinol Metab. 6:115-120.
6. Gantz I, Tashiro T, Barcroft C, et al. 1993 Localization of the genes encoding the melanocortin-2 (ACTH hormone) and melanocortin-3 receptors to chromosome 18p11.2 and 20.q13.2-13.3 by fluorecent in situ hybridization. Genomics. 18:166-167.
7. Vamvakopoulos NC, Durkin S, Nierman W, Chrousos GP. 1993 Mapping the human adrenocorticotropin receptor gene to the small arm of chromosome 18 (18p.11.21-pter). Genomics. 18:454-455.
8. Latronico AC, Reincke M, Mendonca BB, et al. 1995 No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. J Clin Endocrinol Metab. 80:875-877.
9. Estivariz FE, Iturriza F, Mclean C, Hope J, Lowry PJ. 1982 Stimulation of adrenal mitogenesis by N-terminal proopiomelanocortin. Nature. 297: 419-422.
10. Reincke M, Mora P, Beuschlein B, Lehmann R, Karl M, Allolio B. 1995 No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. Exp Clin Endocrinol. 103(Suppl 1):129.
11. Baxter JD, Tyrrel JB. 1986 The adrenal cortex. In: Felig P, Baxter JD, Broadus AE, Frohman LA, eds. Endocrinology and metabolism, 2nd ed. New York: McGraw-Hill; 511-692.
12. Orth DN, Kovacs WJ, DeBold CR. 1992 The adrenal cortex. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinologv, 8th ed. Philadelphia: Saunders; 489-621.
13. Berrettini WH, Ferraro TN, Goldin LR, et al. 1994 Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci USA. 91:5918-5921.
14. Detera-Wadleigh SD, Yoon SW, Berrettini WH, et al. 1995 ACTH receptor/ melanocortin receptor-2 maps within a reported susceptibility for bipolar illness on chromosome 18. Am J Med Genet. 60:317-321.
15. Reincke M, Beuschlein F, Menig G, et al. ACTH receptor mRNA expression in adrenocortical tumors: comparison with P450 steroidogenic enzyme expression. Clin Endocrinol (Oxf). 46:619-626.
16. Lyons J, Landis CA, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
17. Parma J, Duprez L, Van Sande J, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
18. Reincke M, Karl M, Travis W, Chrousos GP. 1993 No evidence for oncogenic mutations in guanine nucleotide binding proteins of human adrenocortical neoplasms. J Clin Endocrinol Metab. 77:1419-1422.
19. Naville D, Barjhoux L, Jaillard C, Lebrethon MC, Saez JM, Begeot M. 1994 Characterization of the transcription start site of the ACTH receptor gene: presence of an intronic sequence in the 5′-flanking region. Mol Cell Endocrinol. 106:131-135.
20. Erlandson RA, Reuter VE. 1991 Oncocytic adrenal cortical adenoma. Ultrastruct Pathol. 15:539-547.
21. Mitchell A, Scheithauer BW, Sasano H, Hubbard EW, Ebersold MJ. 1993 Symptomatic intradural adrenal adenoma of the spinal nerve root: report of two cases. Neurosurgery. 32:658-661.
22. Mackay B, el-Naggar A, Ordonez NG. 1994 Ultrastructure of adrenal cortical carcinoma. Ultrastruct. Pathol. 18:181-190.
23. Schimmer BP, Tsao J, Knapp M. 1977 Isolation of mutant adrenocortical tumor cells resistant to cyclic nucleotides. Mol Cell Endocrinol. 8:135-145.
24. Schimmer BP, Kwan WK, Tsao J, Qiu R. 1995 Adrenocorticotropin-resistant mutants of the Y1 adrenal cell line fail to express the ACTH receptor. J Cell Physiol. 163:164-171.
25. Van der Riet P, Karp D, Farmer E, et al. 1994 Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allel. Cancer Res. 54:27-27.
26. Lin SR, Lee YJ, Tsai JH. 1994 Mutations of the p53 gene in human functional neoplasms. J Clin Endocrinol Metab. 78:483-491.